Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 12—December 2022
Research

Observational Cohort Study of Evolving Epidemiologic, Clinical, and Virologic Features of Monkeypox in Southern France

Nadim CassirComments to Author , Florian Cardona, Hervé Tissot-Dupont, Christiane Bruel, Barbara Doudier, Salima Lahouel, Karim Bendamardji, Céline Boschi, Sarah Aherfi, Sophie Edouard, Jean-Christophe Lagier, Philippe Colson, Philippe Gautret, Pierre-Edouard Fournier, Philippe Parola, Philippe Brouqui, Bernard La-Scola, and Matthieu Million
Author affiliations: IHU-Méditerranée Infection, Marseille, France (N. Cassir, F. Cardona, H. Tissot-Dupont, B. Doudier, S. Lahouel, K. Bendamardji, C. Boschi, S. Aherfi, S. Edouard, J.-C. Lagier, P. Colson, P. Gautret, P.-E. Fournier, P. Parola, P. Brouqui, B. La-Scola, M. Million); Aix-Marseille Université, IRD, AP-HM, MEPHI, Marseille (N. Cassir, H. Tissot-Dupont, C. Boschi, S. Aherfi, S. Edouard, J.-C. Lagier, P. Colson, P. Gautret, P. Brouqui, B. La-Scola, M. Million); Assistance Publique Hôpitaux de Marseille, Marseille (F. Cardona, B. Doudier, S. Lahouel, K. Bendamardji); Regional Health Agency of Provence-Alpes-Côte d'Azur (ARS Paca), Marseille (C. Bruel); Aix Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille (P.-E. Fournier, P. Parola)

Main Article

Table 1

Demographic and epidemiologic characteristics of patients with monkeypox in Marseille during the 2022 outbreak in southern France*

Variable No. patients†
Age, y, median (IQR)
 36 (30–42)
Sex
F 3 (2.2)
M
 133 (97.8)
Sexual orientation
Men who have sex with men 125 (91.9)
Using PrEP 30 (24)
Heterosexual men 2 (1.5)
Heterosexual women
 3 (2.2)
History of smallpox vaccination
Childhood vaccine 7 (5.1)
Postexposure vaccine 6 (4.4)
Preexposure vaccine
 2 (1.5)
HIV-positive
Total 21 (15.4)
<500 CD4/mm3 5 (23.8)
<200 CD4/mm3
 0
Possible exposure to monkeypox
Sexual partner with monkeypox 21 (15.4)
New sexual partners‡ 115 (84.6)
Attendance at a Pride event 7 (5.2)
Recent travel to an endemic country 0
Recent travel to an epidemic country 17 (12.5)

*Values are no. (%) patients except as indicated. PrEP, preexposure prophylaxis; CD4, CD4 T lymphocyte. †Total number of patients in the study was 136. ‡Single or multiple new sexual partners in the previous 21 d.

Main Article

Page created: October 04, 2022
Page updated: November 21, 2022
Page reviewed: November 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external